Scaffold and SAR studies on c-MET inhibitors using machine learning approaches
Open Access
- 10 April 2025
- journal article
- Published by Elsevier in Journal of Pharmaceutical Analysis
- Vol. 15 (6) , 101303
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (32200531)
- National Natural Science Foundation of China (82173699)
- Science and Technology Commission of Shanghai Municipality (23DZ2290600)
- Shanghai Jiao Tong University (20230101)
This publication has 54 references indexed in Scilit:
- Towards safer streets: A framework for unveiling pedestrians’ perceived road safety using street view imageryAccident Analysis & Prevention, 2023
- Lead generation of cysteine based mesenchymal epithelial transition (c-Met) kinase inhibitors: Using structure-based scaffold hopping, 3D-QSAR pharmacophore modeling, virtual screening, molecular docking, and molecular dynamics simulationComputers in Biology and Medicine, 2022
- Safety and Tolerability of c-MET Inhibitors in CancerDrug Safety, 2019
- Discovery of thinopyrimidine-triazole conjugates as c-Met targeting and apoptosis inducing agentsBioorganic Chemistry, 2018
- Discovery of substituted pyrazol-4-yl pyridazinone derivatives as novel c-Met kinase inhibitorsArchives of Pharmacal Research, 2016
- Indazoles as potential c-met inhibitors: Design, synthesis and molecular docking studiesEuropean Journal of Medicinal Chemistry, 2013
- O‐Linked Triazolotriazines: Potent and Selective c‐Met InhibitorsChemMedChem, 2012
- 2,4-Diaminopyrimidine inhibitors of c-Met kinase bearing benzoxazepine anilinesBioorganic & Medicinal Chemistry Letters, 2011
- Discovery of a novel series of quinoxalines as inhibitors of c-Met kinaseBioorganic & Medicinal Chemistry Letters, 2009
- A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor familyCell, 1994